Target intelligence / Profile preview

TBC1D22A antisense RNA 1 (TBC1D22A-AS1)

Target
TBC1D22A-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

TBC1D22A antisense RNA 1 (TBC1D22A-AS1) is a human long non-coding RNA (lncRNA) gene classified as an antisense RNA relative to the protein-coding gene TBC1 domain family member 22A (TBC1D22A)[4][6][9][13]. The transcript is identified as a non-protein-coding RNA and is primarily annotated by genome databases for its genomic location and antisense orientation[4][6][13]. At present, there are no established biological functions, disease associations, or evidence that it serves as a therapeutic target[6][5][13]. There are also no approved drugs, mechanisms of drug action, or clinical biomarker roles for TBC1D22A-AS1, and it is not a member of any known major protein-based molecular family. It is typically included in transcriptomic datasets describing lncRNAs but does not currently have ascribed biomedical significance beyond its annotation as a putative

Other names
TBC1D22A-AS1ENSG00000280080 (Ensembl)NCBI Gene 642757
02

Mechanism of action

Not applicable (no drugs target this gene)

03

Biological functions

Unknownregulatory RNA function possible (no curated function in current data)
04

Disease associations

None establishedno direct disease association reported
05

Safety considerations

None reported
06

Interacting drugs

None known
07

Biomarkers

None reported

Beyond the preview

Go deeper on TBC1D22A antisense RNA 1 (TBC1D22A-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1D22A antisense RNA 1 (TBC1D22A-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call